Key facts
- It has raised $5.6M; the latest was Later Stage VC ($5.6M) in Jun 2025.
- Notable investors include Renaissance Capital (Shanghai).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Guanchi Cells
- ·The full record, as it builds
Funding rounds
No funding rounds for Guanchi Cells are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Guanchi Cells
Provider of regenerative biotechnology intended for clinical and therapeutic applications. The company offers stem cell preservation, cellular therapy development, and biomedical research services, enabling healthcare institutions and research organizations to access advanced regenerative treatment options, support personalized medicine initiatives, and improve long-term patient outcomes through scalable, compliant, and scientifically validated cellular technologies.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2015
- Employees
- 10
- Website
- guanchiganxibao.com/
- Ownership
- Privately Held (backing)
Guanchi Cells doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Guanchi Cells shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Guanchi Cells in its N-PORT filings yet. We sweep new filings monthly.